ACRC Studies
San Diego, California, United States
Medical center in Poway, California
15725 Pomerado Rd Suite - 108, Poway, CA 92064
About ACRC Studies
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
5
Pfizer
3
Arena Pharmaceuticals
2
Biohaven Pharmaceuticals, Inc.
2
Incyte Corporation
2
Biofourmis Inc.
1
Horizon Therapeutics Ireland DAC
1
Millennium Pharmaceuticals, Inc.
1
Oneness Biotech Co., Ltd.
1
Selecta Biosciences, Inc.
1
Zoll Medical Corporation
1
Clinical Trials at ACRC Studies
During the past decade, ACRC Studies conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 7 clinical trials were completed, i.e. on
average, 36.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 7 clinical trials were completed. i.e. 63.6%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus
2018-08-02
2022-03-09
Terminated
830
A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)
2018-11-26
2021-11-04
Completed
58
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)
2019-09-09
2022-04-01
Terminated
1,156
Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
2019-06-13
2022-02-16
Completed
433
Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout
2019-06-13
2022-04-11
Completed
152
Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis
2020-09-15
2021-12-07
Completed
354
Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)
2019-10-03
2021-10-01
Completed
344
A Study of Baricitinib in Participants With Rheumatoid Arthritis
2020-02-14
2026-02-01
Recruiting
1,300
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "ACRC Studies" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Pfizer" with 3 trials
sponsored, "Arena Pharmaceuticals" with 2 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored and "Incyte Corporation"
with 2 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "ACRC Studies"
#1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator and "Dermira, Inc." with 2 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at ACRC Studies
According to Clinical.Site data, the most researched conditions in "ACRC Studies" are
"Atopic Dermatitis" (4 trials), "Systemic Lupus Erythematosus" (3 trials), "Ulcerative Colitis" (3 trials), "Heart Failure" (2 trials) and "Chronic Gout" (1 trials). Many other conditions were trialed in "ACRC Studies" in a lesser frequency.
Clinical Trials Intervention Types at ACRC Studies
Most popular intervention types in "ACRC Studies" are "Drug" (15 trials), "Biological" (4 trials), "Other" (4 trials), "Device" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Etrasimod" (4 trials), "Baricitinib" (3 trials), "Lebrikizumab" (2 trials) and "Vehicle" (2 trials). Other intervention names were less common.
Clinical Trials Genders at ACRC Studies
The vast majority of trials in "ACRC Studies" are
20 trials for "All" genders.
Clinical Trials Status at ACRC Studies
Currently, there are NaN active trials in "ACRC Studies".
undefined are not yet recruiting,
5 are recruiting,
3 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 8 completed trials in ACRC Studies,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in ACRC Studies, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 2 trials that are defined as “Not Applicable".